The White House in October turned down a proposal that would have added more than 730 million at-home COVID tests to the market per month, according to a report this week.
A plan by top industry experts from Harvard’s T.H. Chan School of Public Health, the COVID Collaborative, the Rockefeller Foundation, and other organizations, sought to ramp up manufacturing capabilities “to Prevent Holiday COVID Surge,” first reported Vanity Fair Thursday.
But the White House rejected the Oct. 22 bid and three days later announced it would seek to bolster rapid home testing through the “FDA’s regulatory approval process.”
An administration official present at the October meeting told the publication that the decision was based on the fact that the U.S. “did not have capacity to manufacture over-the-counter tests at that scale.”